Dysconnectivity in the Frontoparietal Attention Network in Schizophrenia
Article 2013 en
Authors
JR
Jonathan P. Roiser
RW
Rebekah Wigton
JK
James M. Kilner
Abstract
1 min read
Cognitive impairment is common in patients with schizophrenia (SZs), and even those with relatively preserved function perform worse than healthy volunteers (HVs) on attentional tasks. This is consistent with the hypothesis that connectivity – in the frontoparietal network (FPN) activated during attention – is disrupted in schizophrenia. We examined attentional effects on connectivity in the FPN, in schizophrenia, using magnetoencephalography (MEG). Twenty-three HVs and 19 first-episode SZs were scanned during a simple visual change test, known to activate the FPN, in which attention was monitored and directed with an orthogonal flicker detection task. Dynamic causal modelling (DCM) of evoked responses was used to assess effective connectivity – and its modulation by changes in the attended stimulus dimension – in the following network: higher visual area; temporoparietal junction (TPJ); intraparietal sulcus (IPS); dorsal anterior cingulate cortex; and ventrolateral prefrontal cortex. The final MEG analysis included 18 HVs and 14 SZs. While all participants were able to maintain attention, HVs responded slightly, but non-significantly, more accurately than SZs. HVs, but not SZs, exhibited greater cortical responses to attended visual changes. Bayesian model comparison revealed that a DCM with attention dependent changes in both top-down and bottom-up connections best explained responses by SZs, while in HVs the best model required only bottom-up changes. Quantitative comparison of connectivity estimates revealed a significant group difference in changes in the right IPS-TPJ connection: SZs showed relative reductions in connectivity during attended stimulus changes. Crucially, this reduction predicted lower intelligence. These data are consistent with the hypothesis that functional dysconnections in the FPN contribute to cognitive impairment in schizophrenia.
Discussion(0)
No comments yet. Be the first to comment.